X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (381) 381
male (332) 332
female (323) 323
middle aged (296) 296
aged (239) 239
gastroenterology & hepatology (226) 226
adult (202) 202
index medicus (199) 199
hepatocellular carcinoma (155) 155
electricity (152) 152
physics (118) 118
basic electric elements (108) 108
interferon (99) 99
prognosis (97) 97
treatment outcome (92) 92
genotype (89) 89
hepatitis c virus (89) 89
chemistry (84) 84
antiviral agents - therapeutic use (83) 83
metallurgy (82) 82
hepatitis c (80) 80
analysis (76) 76
hepatitis c, chronic - drug therapy (76) 76
performing operations (76) 76
transporting (76) 76
hepacivirus - genetics (74) 74
virology (72) 72
chronic hepatitis c (67) 67
japan (66) 66
aged, 80 and over (65) 65
hepatitis (65) 65
oncology (64) 64
hepatocellular-carcinoma (62) 62
liver (61) 61
liver cancer (61) 61
ribavirin (60) 60
therapy (60) 60
hepatoma (59) 59
health aspects (57) 57
retrospective studies (57) 57
time factors (57) 57
carcinoma, hepatocellular - pathology (56) 56
liver neoplasms - pathology (56) 56
follow-up studies (55) 55
hepatology (55) 55
care and treatment (54) 54
risk factors (54) 54
hepatitis c, chronic - virology (53) 53
interferon-alpha - therapeutic use (53) 53
diagnosis (52) 52
infection (52) 52
medicine & public health (52) 52
cirrhosis (51) 51
multivariate analysis (51) 51
gastroenterology (49) 49
general tagging of cross-sectional technologies spanning over several sections of the ipc (49) 49
general tagging of new technological developments (49) 49
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (49) 49
genotypes (46) 46
electric discharge tubes or discharge lamps (43) 43
hepatitis b virus - genetics (43) 43
adolescent (42) 42
antiviral agents - administration & dosage (42) 42
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (42) 42
drug therapy, combination (42) 42
frequency-changing (42) 42
non-linear optics (42) 42
optical analogue/digital converters (42) 42
optical logic elements (42) 42
optics (42) 42
techniques or procedures for the operation thereof (42) 42
cancer (41) 41
patients (41) 41
blasting (40) 40
genetic aspects (40) 40
heating (40) 40
hepatitis b virus (40) 40
lighting (40) 40
mechanical engineering (40) 40
technologies or applications for mitigation or adaptation againstclimate change (40) 40
vehicles in general (40) 40
weapons (40) 40
hepatitis b (39) 39
japan - epidemiology (39) 39
electric solid state devices not otherwise provided for (38) 38
liver neoplasms - mortality (38) 38
semiconductor devices (38) 38
survival (38) 38
alanine transaminase - blood (37) 37
carcinoma, hepatocellular - mortality (37) 37
fibrosis (37) 37
liver cirrhosis (37) 37
mutation (37) 37
risk (36) 36
risk-factors (36) 36
colorectal surgery (35) 35
interferon therapy (35) 35
interferon-alpha - administration & dosage (35) 35
recurrence (35) 35
rna, viral - blood (35) 35
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastroenterology, ISSN 0944-1174, 11/2016, Volume 51, Issue 11, pp. 1081 - 1089
Journal Article
Hepatology, ISSN 0270-9139, 08/2017, Volume 66, Issue 2, pp. 510 - 517
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 1/2017, Volume 52, Issue 1, pp. 104 - 112
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 4/2017, Volume 52, Issue 4, pp. 512 - 519
Lenvatinib is an oral inhibitor of vascular endothelial growth factor receptor 1–3, fibroblast growth factor receptor 1–4, platelet-derived growth factor... 
E7080 | Medicine & Public Health | Colorectal Surgery | Tyrosine kinase inhibitor | Hepatology | Gastroenterology | Abdominal Surgery | Hepatocellular carcinoma | Vascular endothelial growth factor inhibitor | Lenvatinib | Surgical Oncology | MODIFIED RECIST | RESPONSE EVALUATION CRITERIA | SERUM | KINASE INHIBITOR | SORAFENIB | GASTROENTEROLOGY & HEPATOLOGY | ENDOTHELIAL GROWTH-FACTOR | Body Weight | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Quinolines - administration & dosage | Carcinoma, Hepatocellular - diagnostic imaging | Young Adult | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Drug Administration Schedule | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Phenylurea Compounds - therapeutic use | Liver Neoplasms - diagnostic imaging | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Phenylurea Compounds - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Quinolines - therapeutic use | Neoplasm Staging | Quinolines - adverse effects | Tyrosine | Complications and side effects | Medical research | Care and treatment | Medicine, Experimental | Hepatoma | Growth factors | Endothelium | Index Medicus | Original —Liver, Pancreas, and Biliary Tract
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 11/2018, Volume 33, Issue 11, pp. 1904 - 1911
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 01/2019, Volume 34, Issue 1, pp. 207 - 214
Journal Article
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 11/2017, Volume 32, Issue 11, pp. 1879 - 1886
Journal Article
Journal Article
Liver International, ISSN 1478-3223, 03/2018, Volume 38, Issue 3, pp. 484 - 493
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 12/2018, Volume 25, Issue 12, pp. 1446 - 1451
Summary The optimal term of follow‐up for patients who achieve sustained virological responses (SVR) is an important topic because of the widespread use of... 
direct‐acting antiviral | hepatitis C virus | late relapse | sustained virological response | direct-acting antiviral | INFECTIOUS DISEASES | RISK | INTERFERON-FREE | B-VIRUS | HEPATOCELLULAR-CARCINOMA | VIROLOGY | REACTIVATION | REINFECTION | GASTROENTEROLOGY & HEPATOLOGY | Antiviral agents | Relapse | Care and treatment | Hepatitis C virus | Diseases
Journal Article